Skip to content

Insider · CIK 0002128014

Chris Crisafulli

officer

Files at GRDN (Guardian Pharmacy Services, Inc.). First filing -, latest -.

In brief

Chris Crisafulli files SEC Form 4 as officer at GRDN (Guardian Pharmacy Services, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Chris Crisafulli has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 27, 2026GRDN
Guardian Pharmacy Services, Inc.
MOption exercise
Class A Common Stock
+18,931--53,05716 d ago
Sep 27, 2026GRDN
Guardian Pharmacy Services, Inc.
MOption exercise
Class B Common Stockderivative
-18,931--016 d ago

Questions about Chris Crisafulli

Answered from the filings on this page, as of the latest one.

Is Chris Crisafulli buying or selling?

Chris Crisafulli has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Chris Crisafulli's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chris Crisafulli has 0.

Where does Chris Crisafulli file Form 4?

Chris Crisafulli has filed Form 4 at GRDN (Guardian Pharmacy Services, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Chris Crisafulli: insider trades and track record | InsiderTell